Anti-NMDA Receptor Encephalitis Overview

Save information for later
Sign Up

Learn About Anti-NMDA Receptor Encephalitis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Anti-NMDA Receptor Encephalitis Local Doctors?
Elite in Anti-NMDA Receptor Encephalitis
Elite in Anti-NMDA Receptor Encephalitis

Erasmus MC

Rotterdam, ZH, NL 

Maarten Titulaer practices in Rotterdam, Netherlands. Titulaer is rated as an Elite expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. Their top areas of expertise are Anti-NMDA Receptor Encephalitis, Encephalitis, Lambert-Eaton Syndrome, and Hashimoto Thyroiditis.

Elite in Anti-NMDA Receptor Encephalitis
Elite in Anti-NMDA Receptor Encephalitis
Barcelona, CT, ES 

Mar Guasp practices in Barcelona, Spain. Guasp is rated as an Elite expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. Their top areas of expertise are Anti-NMDA Receptor Encephalitis, Encephalitis, Hashimoto Thyroiditis, and Herpes Simplex Encephalitis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Anti-NMDA Receptor Encephalitis
Elite in Anti-NMDA Receptor Encephalitis
Sagamihara, JP 

Takahiro Iizuka-Takiyama practices in Sagamihara, Japan. Mr. Iizuka-Takiyama is rated as an Elite expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. His top areas of expertise are Anti-NMDA Receptor Encephalitis, Encephalitis, Stiff Person Syndrome, and Status Epilepticus.

What are the latest Anti-NMDA Receptor Encephalitis Clinical Trials?
Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis

Summary: Autoimmune encephalitis is an autoimmune disease of the central nervous system that targets neuronal autoantigens. Anti-neuronal autoantibodies are produced in patients, with anti-NMDAR antibody being the most common.Anti-NMDAR encephalitis can be severe and life-threatening. Anti-NMDAR autoantibodies against neurons are pathogenic and are mainly produced by autoreactive B cells and plasma cells. ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-Nmda Receptor Encephalitis and Assess Markers of Disease

Summary: Determine the difference in the modified Rankin score at 16 weeks in participants with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis treated with first-line immunomodulatory therapies provided as standard-of-care, and either inebilizumab (investigational agent) or placebo.